IL6 and COVID-19: IL-6, a common characteristic cytokine that participates in cytokine storm, is not only a clinical predictor of mortality in patients with COVID-19 [39], but also an underlying target for decreasing atherosclerosis-related cardiovascular morbidity and mortality [87, 88].